{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":5,"sponsored":0,"items":[{"id":"n_i5x7jnoqwxlh4mf5zsoq","seq":861853,"kind":"article","title":"Roche Unveils Newborn Screening Test For 3 Genetic Conditions Of SMA, SCID, Sickle Cell Disease","url":"https://www.rttnews.com/3695085/roche-unveils-newborn-screening-test-for-3-genetic-conditions-of-sma-scid-sickle-cell-disease.aspx","published":"2026-09-30T06:20:00Z","seen":"2026-09-30T08:55:33Z","lang":"en","source":{"id":"rttnews.com","name":"rttnews.com","domain":"rttnews.com","outlet":{"wikidata":"Q60748698","name":"RTTNews","type":"news_agency","designations":["news agency","news website"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q2160232","name":"Roche","type":"org"},{"id":"Q580290","name":"spinal muscular atrophy","type":"other"},{"id":"Q1334408","name":"severe combined immunodeficiency","type":"other"}],"story":"st_4mntj4konxce2a3aekkq","category":"health","category_p":0.76,"sentiment":"neutral","tone":-0.33,"political":0.04},{"id":"n_bxsbuxn4nnwfqko42isa","seq":659477,"kind":"article","title":"SMA battery inverter first to win grid-forming certification for German inertia market","url":"https://www.energy-storage.news/sma-battery-inverter-first-to-win-grid-forming-certification-for-german-inertia-market","summary":"Inverter manufacturer SMA Solar Technology has become the first to be certified as capable of providing inertia to the German grid.","published":"2026-09-29T11:37:42Z","seen":"2026-09-29T11:47:03Z","lang":"en","source":{"id":"kite-energy-storage-news-127a68","name":"energy-storage.news","domain":"energy-storage.news"},"via":"kite-energy-storage-news-127a68","topics":["energy","news","certification","germany","gfm","grid-forming","inertia","inverter"],"authors":["Andy Colthorpe"],"entities":[{"id":"Q580290","name":"spinal muscular atrophy","type":"org"}],"image":"https://www.energy-storage.news/wp-content/uploads/2026/09/SMA-Foehren_Pressebild-768x595.jpg","story":"st_bxsbuxn4nnwfqko42isa","category":"economy-business","category_p":0.85,"sentiment":"positive","tone":0.51,"political":0.02},{"id":"n_jg5cgbwajar7p4iks2yq","seq":624779,"kind":"article","title":"SMA erhält erste Zertifizierung nach VDE-FNN-Hinweis für Deutschlands neuen Momentanreserve-Markt","title_en":"SMA receives first certification for Germany's new instantaneous reserve market","url":"https://energynews.ch/sma-erhaelt-erste-zertifizierung-nach-vde-fnn-hinweis-fuer-deutschlands-neuen-momentanreserve-markt","summary":"Die SMA Solar Technology AG (SMA) hat die erste Zertifizierung nach dem VDE-FNN-Hinweis Technische Anforderungen an Netzbildende Eigenschaften inklusive der Bereitstellung von Momentanreserve erhalten. Die Zertifizierung markiert einen wichtigen Meilenstein auf dem Weg zur breiteren Nutzung netzbildender Technologien in Großbatteriespeichern und unterstreicht die führende Rolle von SMA bei netzbildenden Technologien und Lösungen für Netzstabilität. Mit [...]","published":"2026-09-29T08:50:06Z","seen":"2026-09-29T09:13:55Z","lang":"de","source":{"id":"kite-energynews-ch-69b6fa","name":"energynews.ch","domain":"energynews.ch"},"via":"kite-energynews-ch-69b6fa","topics":["energy","aktuelles","nachhaltigkeit","sma"],"authors":["Schweizer Fachmedien"],"entities":[{"id":"Q580290","name":"spinal muscular atrophy","type":"org"}],"story":"st_jg5cgbwajar7p4iks2yq","category":"economy-business","category_p":0.75,"sentiment":"neutral","tone":0.43,"political":0.02},{"id":"n_ez2333tdkevrdkr7vwsa","seq":562005,"kind":"article","title":"Emugrobar、肥満症での開発を中止しSMAで開発再開","url":"https://medical-tribune.co.jp/rensai/articles?blogid=11&entryid=616208","summary":"中外製薬は昨日（9月28日）、自社が創出しスイス・ロシュが開発中の潜在型ミオスタチンスイーピング抗体emugrobart（開発コードGYM329）について、肥満症を対象とした臨床開発を中止し、ロシュによる同薬の開発を終了することを決定したと発表した。これに伴い同薬に関する全てのライセンス権が中外製薬に返還される。 今回の決定は、肥満症患者を対象に実施中の第Ⅱ相GYMINDA試験の中間解析結果を含...","published":"2026-09-29T02:30:47Z","seen":"2026-09-29T02:30:47Z","lang":"en","source":{"id":"kite-medical-tribune-co-jp-14fcf3","name":"medical-tribune.co.jp","domain":"medical-tribune.co.jp"},"via":"kite-medical-tribune-co-jp-14fcf3","topics":["medicine","新薬エクスプレス"],"entities":[{"id":"Q580290","name":"spinal muscular atrophy","type":"other"}],"image":"https://asset.mtweb.jp/media/2026/09/14145140/com_pressb_thum_w440h275-2.jpg","story":"st_ez2333tdkevrdkr7vwsa","category":"health","category_p":0.49,"category2":"economy-business","sentiment":"neutral","tone":0.1,"political":0.02},{"id":"n_54xfboafu3elu3ez3lqq","seq":503255,"kind":"article","title":"Chugai Regains Rights To Emugrobart, Shifts Focus Back To SMA Development","url":"https://www.rttnews.com/3694433/chugai-regains-rights-to-emugrobart-shifts-focus-back-to-sma-development.aspx","published":"2026-09-28T16:55:00Z","seen":"2026-09-28T19:13:29Z","lang":"en","source":{"id":"rttnews.com","name":"rttnews.com","domain":"rttnews.com","outlet":{"wikidata":"Q60748698","name":"RTTNews","type":"news_agency","designations":["news agency","news website"]}},"via":"gdelt-gkg-english","topics":["business","economy","health"],"entities":[{"id":"Q580290","name":"spinal muscular atrophy","type":"other"}],"story":"st_54xfboafu3elu3ez3lqq","category":"economy-business","category_p":0.78,"sentiment":"neutral","tone":0.14,"political":0.2}]}